194 related articles for article (PubMed ID: 35005991)
1. Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.
Amiri-Dashatan N; Koushki M; Rezaei-Tavirani M
OMICS; 2022 Jan; 26(1):19-34. PubMed ID: 35005991
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.
Ray S; Srivastava S
OMICS; 2020 Aug; 24(8):457-459. PubMed ID: 32427517
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
[TBL] [Abstract][Full Text] [Related]
4. CoVProt: Toward a Mass Spectrometry Data Portal for COVID-19 Proteomics Research and Development.
Rajoria S; Kavuru SR; Pyda HS; Bihani S; Borishetty D; Biswas D; Prajapati J; Paladi H; Srivastava S
OMICS; 2024 Jan; 28(1):24-31. PubMed ID: 38193774
[TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
Mahmud I; Garrett TJ
J Am Soc Mass Spectrom; 2020 Oct; 31(10):2013-2024. PubMed ID: 32880453
[TBL] [Abstract][Full Text] [Related]
6. Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications.
Tan HW; Xu YM; Lau ATY
Expert Rev Proteomics; 2021 Nov; 18(11):925-938. PubMed ID: 34812694
[TBL] [Abstract][Full Text] [Related]
7. Proteomics-based mass spectrometry profiling of SARS-CoV-2 infection from human nasopharyngeal samples.
Chatterjee S; Zaia J
Mass Spectrom Rev; 2024; 43(1):193-229. PubMed ID: 36177493
[TBL] [Abstract][Full Text] [Related]
8. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N
J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry Approaches for SARS-CoV-2 Detection: Harnessing for Application in Food and Environmental Samples.
Bojórquez-Velázquez E; Llamas-García ML; Elizalde-Contreras JM; Zamora-Briseño JA; Ruiz-May E
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632614
[TBL] [Abstract][Full Text] [Related]
10. Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?
Acharjee A; Stephen Kingsly J; Kamat M; Kurlawala V; Chakraborty A; Vyas P; Vaishnav R; Srivastava S
Expert Rev Proteomics; 2022 Mar; 19(3):197-212. PubMed ID: 35655386
[TBL] [Abstract][Full Text] [Related]
11. Multiomics integration-based molecular characterizations of COVID-19.
Li CX; Gao J; Zhang Z; Chen L; Li X; Zhou M; Wheelock ÅM
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864875
[TBL] [Abstract][Full Text] [Related]
12. Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses.
Sperk M; van Domselaar R; Rodriguez JE; Mikaeloff F; Sá Vinhas B; Saccon E; Sönnerborg A; Singh K; Gupta S; Végvári Á; Neogi U
J Proteome Res; 2020 Nov; 19(11):4259-4274. PubMed ID: 33095583
[TBL] [Abstract][Full Text] [Related]
13. Perspective on Proteomics for Virus Detection in Clinical Samples.
Grossegesse M; Hartkopf F; Nitsche A; Schaade L; Doellinger J; Muth T
J Proteome Res; 2020 Nov; 19(11):4380-4388. PubMed ID: 33090795
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Preparing Planetary Health for Future Ecological Crises: Hopes from Glycomics for Vaccine Innovation.
Wang X; Zhong Z; Wang W
OMICS; 2021 Apr; 25(4):234-241. PubMed ID: 33794117
[TBL] [Abstract][Full Text] [Related]
15. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
[TBL] [Abstract][Full Text] [Related]
16. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
Aggarwal S; Acharjee A; Mukherjee A; Baker MS; Srivastava S
J Proteome Res; 2021 Feb; 20(2):1107-1132. PubMed ID: 33426872
[TBL] [Abstract][Full Text] [Related]
17. Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target?
Rex DAB; Arun Kumar ST; Modi PK; Keshava Prasad TS
OMICS; 2021 Jul; 25(7):408-416. PubMed ID: 34191617
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects.
Li S; Li S; Disoma C; Zheng R; Zhou M; Razzaq A; Liu P; Zhou Y; Dong Z; Du A; Peng J; Hu L; Huang J; Feng P; Jiang T; Xia Z
Rev Med Virol; 2021 Mar; 31(2):e2168. PubMed ID: 35349206
[TBL] [Abstract][Full Text] [Related]
19. Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.
Whetton AD; Preston GW; Abubeker S; Geifman N
J Proteome Res; 2020 Nov; 19(11):4219-4232. PubMed ID: 32657586
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and Preparing for Future Ecological Crises: Hopes from Metagenomics in Facing Current and Future Viral Pandemic Challenges.
Fulci V; Carissimi C; Laudadio I
OMICS; 2021 Jun; 25(6):336-341. PubMed ID: 34037469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
